Erratum to: J Mol Med. 2010 Dec;88(12):1243-53
DOI 10.1007/s00109-010-0669-3
The authors claim that Figs. 5a and b, and 6a and d, reporting data from in vitro invasion assays were published incorrectly. Specifically, two images of invaded cells were by mistake duplicated. The authors performed 2 additional experiments to confirm their data. The results from these experiments are reported in the corrected versions of the figures and legends, as well as the corresponding results section that are shown below. The authors claim that this correction does not influence the conclusion of the study and would like to apologize for this oversight.
Results
CXCR4 is essential for CXCL12-induced invasion
Disruption of CXCR4 and CXCL12 interaction by selective antagonists or anti-CXCR4 antibody blocks cancer metastasis, suggesting an essential role for CXCR4. Therefore, when HCT116 cells were transfected with siRNA specific for CXCR4, it efficiently inhibited CXCL12-mediated invasion to about 31 % compared to the control condition. (Fig. 5a, b). Indeed, the CXCR4-specific siRNA reduced CXCR4 protein expression (Fig. 5c).
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s00109-010-0669-3.
Rights and permissions
About this article
Cite this article
Yadav, V.R., Sung, B., Prasad, S. et al. Erratum to: Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor. J Mol Med 91, 407–408 (2013). https://doi.org/10.1007/s00109-012-0987-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-012-0987-8